| Title: |
Association Between Discharge Medications and Oncologic Post‐Embolization‐Syndrome‐Related Outcomes |
| Authors: |
Hanzhou Li; John Moon; Nathan Sim; Michal Horný; Nicholas Lima; Menelaos Konstantinidis; Deepak Iyer; Sonia Benenati; Judy Gichoya; Janice Newsome; Zachary Bercu |
| Source: |
Cancer Medicine, Vol 14, Iss 23, Pp n/a-n/a (2025) |
| Publisher Information: |
Wiley, 2025. |
| Publication Year: |
2025 |
| Collection: |
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
| Subject Terms: |
chemoembolization; hepatocellular carcinoma; opioids; post‐embolization syndrome; radioembolization; readmission; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282 |
| Description: |
ABSTRACT Background Post‐embolization syndrome after transarterial chemoembolization (TACE) and Yttrium‐90 radioembolization (TARE) causes significant morbidity. Understanding whether discharge prescriptions influence short‐term outcomes may guide standardized pain‐management strategies. Methods A retrospective cohort study of 3191 patients (3988 procedures) with hepatocellular carcinoma from the Merative MarketScan Databases (2009–2022) was performed. The composite outcome was 7‐day drug escalation or hospital readmission. Bivariate logistic regression identified candidate variables (p |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
2045-7634 |
| Relation: |
https://doaj.org/toc/2045-7634 |
| DOI: |
10.1002/cam4.71418 |
| Access URL: |
https://doaj.org/article/5e209a7ebbb64ba7b0e793e8a8e83fed |
| Accession Number: |
edsdoj.5e209a7ebbb64ba7b0e793e8a8e83fed |
| Database: |
Directory of Open Access Journals |